Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrazinamide Boosted With Allopurinol in Healthy Volunteers
NCT02700347Phase 1Completed
- Sponsor
- National University Hospital
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of allopurinol in Tuberculosis (TB) (3 arms), sponsored by National University Hospital. Primary endpoint: Cumulative Whole Blood Bactericidal Activity at 48 hours. Started Feb 2016; status: completed.
02
Drugs
allopurinol
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02700347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700347.